SCOLR Pharma, Inc. - Investor Relations

Investors

Overview
Annual Reports
Current SEC Filings
    2007 SEC Filings
    2006 SEC Filings
    2005 SEC Filings
    2004 SEC Filings
    2003 SEC Filings
Corporate Governance
Investor FAQ

2003 SEC Filings

11/14/2003 -

Prospectus

11/14/2003 -
Form 10QSB For The Quarterly Period Ended September 30, 2003

Exhibit 10.1, Consulting Agreement

Exhibit 31.1, Certification of Daniel O. Wilds

Exhibit 31.2, Certification of Steven H. Moger

Exhibit 32.1, Certification of Daniel O. Wilds

Exhibit 32.2, Certification of Steven H. Moger

11/12/2003 -
Form 8K

Exhibit 99, Press Release

10/30/2003 -

Amendment to Form S-2

Exhibit 23.1, Consent of Grant Thornton LLP

10/8/2003 -
Form 10QSB/A For The Quarterly Period Ended June 30, 2003

Exhibit 31.1, Certification of Daniel O. Wilds

Exhibit 31.2, Certification of Steven H. Moger

Exhibit 32.1, Certification of Daniel O. Wilds

Exhibit 32.2, Certification of Steven H. Moger

10/3/2003 -

Amendment to Form S-2

Exhibit 5.1, Consent and Opinion of Garvey Schubert Barer

Exhibit 10.21, Lease

Exhibit 23.1, Consent of Grant Thornton LLP

Exhibit 24.4, Power of Attorney

8/14/2003 -
Form 8K

8/14/2003 -

Form 10QSB For The Quarterly Period Ended June 30, 2003

Exhibit 31.1, Certification of Daniel O. Wilds

Exhibit 31.2, Certification of Steven H. Moger

Exhibit 32.1, Certification of Daniel O. Wilds

Exhibit 32.2, Certification of Steven H. Moger

8/13/2003 -

Form S-2

Exhibit 5.1, Consent and Opinion of Garvey Schubert Barer

Exhibit 10.2, 6.0% Convertible Note

Exhibit 10.3, Common Stock Purchase Warrant

Exhibit 10.4, Convertible Note Purchase Agreement

Exhibit 10.8, Incentive Stock Option Agreement

Exhibit 10.9, Nonqualified Stock Option Agreement

Exhibit 10.11, Research and Transfer Agreement

Exhibit 10.12, License Agreement

Exhibit 10.13, License Agreement

Exhibit 10.14, Master Research and Development Agreement

Exhibit 10.15, Consulting Agreement

Exhibit 10.16, Intellectual Property Assignment and Assumption Agreement

Exhibit 10.17, License Agreement

Exhibit 10.18, Intellectual Property Assignment and Assumption Agreement

Exhibit 10.19, Additional Services Agreement

Exhibit 10.24, Amendment to Building Lease

Exhibit 10.25, Office Lease Agreement

Exhibit 10.27, Employment Agreement

Exhibit 10.28, Separation Agreement

Exhibit 10.29, Advisory Agreement

Exhibit 23.1, Consent of Grant Thornton LLP

Exhibit 24.1, Power of Attorney

Exhibit 24.2, Power of Attorney

Exhibit 24.3, Power of Attorney

Exhibit 24.4, Power of Attorney